VARICELLA ZOSTER VIRUS (VZV) VACCINE

Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include at least one RNA polynucleotides having an open reading frame encoding at least one varicella zoster virus (VZV) antigen. Methods for preparing and using such vaccines are also described.

Saved in:
Bibliographic Details
Main Author Ciaramella, Giuseppe
Format Patent
LanguageEnglish
Published 05.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include at least one RNA polynucleotides having an open reading frame encoding at least one varicella zoster virus (VZV) antigen. Methods for preparing and using such vaccines are also described.
Bibliography:Application Number: US201816494162